Publications
Publications
Embedded Files
Sharma, M., & Naidu, S. SPRTN regulates RNA Polymerase I transcription and dampens chemosensitivity in non-small cell lung cancer. Oncogene. (Manuscript under review).
Sharma, M., et al., & Naidu, S. Pharmacological inhibition of SPRTN by SPL-1 overcomes cellular drug resistance. (Manuscript under preparation).
Sharma, M., et al & Naidu, S. has_PolR1A_circ_402314 inhibition leads to reduced tumor-progression in lung adenocarcinoma (Manuscript under preparation).
Sarkar SS, Sharma M, Karmakar A, Jahan K, Saproo S, Biswas S, Nautiyal S, Roy I, Bharatam PV, Naidu S. NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy. J Transl Med. 2025 Oct 20;23(1):1131. doi: 10.1186/s12967-025-06588-y. PMID: 41116164; PMCID: PMC12538875.
Sarkar, S. S., Sharma, M., Saproo, S., & Naidu, S. (2024). LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma. Journal of Translational Medicine, 22(1), 904.
Pratama, A. M., Sharma, M., Naidu, S., Bömmel, H., Prabhuswamimath, S. C., Thati, M., ... & Karnati, S. (2024). Peroxisomes and PPARs: Emerging role as master regulators of cancer metabolism. Molecular Metabolism, 102044.
Saproo S, Sarkar SS, Gautam V, Konyak CW, Dass G, Karmakar A, Sharma M, Ahuja G, Gupta A, Tayal J, Mehta A, Naidu S. Salivary protein kinase C alpha and novel microRNAs as diagnostic and therapeutic resistance markers for oral squamous cell carcinoma in Indian cohorts. Front Mol Biosci. 2023 Jan 10;9:1106963. doi: 10.3389/fmolb.2022.1106963. PMID: 36703917; PMCID: PMC9871261.
Report abuse